Aspirin 75mg tablets

البلد: المملكة المتحدة

اللغة: الإنجليزية

المصدر: MHRA (Medicines & Healthcare Products Regulatory Agency)

العنصر النشط:

Aspirin

متاح من:

Alissa Healthcare Research Ltd

ATC رمز:

B01AC06

INN (الاسم الدولي):

Aspirin

جرعة:

75mg

الشكل الصيدلاني:

Oral tablet

طريقة التعاطي:

Oral

الفئة:

No Controlled Drug Status

نوع الوصفة الطبية :

Valid as a prescribable product

ملخص المنتج:

BNF: 02090000; GTIN: 5023534009801

نشرة المعلومات

Q2344
Q2344
THIS LEAFLET WAS LAST REVISED IN MARCH 2020

خصائص المنتج

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Aspirin 75mg Dispersible Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Aspirin 75mg
Excipient with known effect
Lactose 0.0275g
For the full list of Excipients, see section 6.1
3
PHARMACEUTICAL FORM
Dispersible tablets.
White, flat tablets, embossed on one side.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
For the secondary prevention of thrombotic cerebrovascular or
cardiovascular
disease and following by-pass surgery.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
The advice of a doctor should be sought before commencing therapy for
the
first time.
The usual dosage, for long term use, is 75-150mg once daily. In some
circumstances a higher dose may be appropriate, especially in the
short term,
and up to 300 mg a day may be used on the advice of a doctor.
Do not give to children aged under 16 years, unless specifically
indicated (e.g.
for Kawasaki’s disease).
Method of administration
Oral
Tablets should be dissolved in water before being taken.
Gastro-intestinal irritation may be reduced by taking aspirin with or
immediately after food.
4.3
CONTRAINDICATIONS
•
Hypersensitivity to the active substance or to any of the excipients
listed in section 6.1. In patients with a history of hypersensitivity
to
aspirin (or any of the excipients) or any other NSAIDs and in patients
in
whom attacks of asthma, angioedema, urticaria or rhinitis have been
precipitated by aspirin or other NSAIDs.
•
Children under 16 years unless specifically indicated (e.g. for
Kawasaki’s disease)._ _
•
Active peptic ulceration or a history of peptic ulceration
•
Haemophilia,_ _other coagulopathies or concurrent anticoagulant
therapy._ _
•
Before commencing long-term aspirin therapy for the management of
cardiovascular or cerebrovascular disease patients should consult
their
doctor who can advise on the relative benefits of aspirin versus the
risks for the individual patient.
•
Gout
•
Doses > 100mg/day during the third trimester of pregnancy.
4.